Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05546580
Title Study of Iadademstat and Gilteritinib in Patients With R/R AML With FMS-like Tyrosine Kinase Mutation (FLT3 Mut+) (FRIDA)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Oryzon Genomics S.A.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Banner MD Anderson Cancer Center RECRUITING Gilbert Arizona 85234 United States Details
The University of Arizona Cancer Center - North Campus RECRUITING Tucson Arizona 85724-5024 United States Details
Sylvester Comprehensive Cancer Center RECRUITING Miami Florida 33136 United States Details
Miami Cancer Institute RECRUITING Miami Florida 33176 United States Details
The John Hopkins University School of Medicine RECRUITING Baltimore Maryland 21287-0013 United States Details
Massachusetts General Hospital (MGH) RECRUITING Boston Massachusetts 02114 United States Details
Rutgers, The State University RECRUITING Piscataway New Jersey 08854 United States Details
Icahn School of Medicine at Mount Sinai and Mount Sinai Hospital RECRUITING New York New York 10029 United States Details
The Ohio State University Wexner Medical Center RECRUITING Columbus Ohio 43210 United States Details
Oregon Health & Science University RECRUITING Portland Oregon 97239 United States Details
UPMC Hillman Cancer Center RECRUITING Pittsburgh Pennsylvania 15232 United States Details
Sarah Cannon Research Institute, LLC RECRUITING Nashville Tennessee 37203 United States Details
West Virginia University RECRUITING Morgantown West Virginia 26506 United States Details
Froedtert Hospital & The Medical College of Wisconsin RECRUITING Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field